MX363538B - Solucion de eluyente. - Google Patents
Solucion de eluyente.Info
- Publication number
- MX363538B MX363538B MX2013007699A MX2013007699A MX363538B MX 363538 B MX363538 B MX 363538B MX 2013007699 A MX2013007699 A MX 2013007699A MX 2013007699 A MX2013007699 A MX 2013007699A MX 363538 B MX363538 B MX 363538B
- Authority
- MX
- Mexico
- Prior art keywords
- radiofluorination
- preparation
- present
- prepared
- eluent solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B9/00—General methods of preparing halides
- C01B9/08—Fluorides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invención proporciona un novedoso método para la preparación de 18F-fluoruro (18F) para uso en reacciones de radiofluoración. El método de la invención encuentra uso especialmente en la preparación de trazadores de tomografía de emisión de positrones (PET) 18F-etiquetados. El método de la invención es particularmente ventajoso sonde las soluciones a granel son preparadas y almacenadas envíales prellenados en lugar de ser recién preparadas en el día de síntesis. La presente invención también proporciona una reacción de radiofluoración, la cual comprende el método de la invención, así como un casete para uso para realizar el método de la invención y/o el método de radiofluoración de la invención en un aparato de radiosintesis automatizado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061427839P | 2010-12-29 | 2010-12-29 | |
PCT/EP2011/073670 WO2012089594A1 (en) | 2010-12-29 | 2011-12-21 | Eluent solution |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013007699A MX2013007699A (es) | 2013-08-15 |
MX363538B true MX363538B (es) | 2019-03-27 |
Family
ID=45495902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013007699A MX363538B (es) | 2010-12-29 | 2011-12-21 | Solucion de eluyente. |
Country Status (16)
Country | Link |
---|---|
US (3) | US11504430B2 (es) |
EP (2) | EP2658831B1 (es) |
JP (1) | JP6018581B2 (es) |
KR (3) | KR102218263B1 (es) |
CN (2) | CN108218650A (es) |
AU (1) | AU2011351550B2 (es) |
BR (2) | BR112013015396B1 (es) |
CA (1) | CA2823063C (es) |
DK (3) | DK2658831T3 (es) |
ES (2) | ES2621950T3 (es) |
MX (1) | MX363538B (es) |
PL (2) | PL2658831T3 (es) |
PT (2) | PT3766522T (es) |
RU (1) | RU2608932C2 (es) |
SG (1) | SG10201805198TA (es) |
WO (1) | WO2012089594A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2793954B1 (en) * | 2011-12-21 | 2020-10-21 | GE Healthcare Limited | 18f-fluciclovine compositions in citrate buffers |
CN108218650A (zh) * | 2010-12-29 | 2018-06-29 | 通用电气健康护理有限公司 | 洗脱溶液 |
IN2014MN00875A (es) * | 2011-10-19 | 2015-04-17 | Piramal Imaging Sa | |
GB201411569D0 (en) | 2014-06-30 | 2014-08-13 | Ge Healthcare Ltd | Novel formulation and method of synthesis |
US11534494B2 (en) | 2011-12-21 | 2022-12-27 | Ge Healthcare Limited | Formulation and method of synthesis |
GB201214220D0 (en) * | 2012-08-09 | 2012-09-19 | Ge Healthcare Ltd | Radiosynthesis |
GB201221266D0 (en) | 2012-11-27 | 2013-01-09 | Ge Healthcare Ltd | Aldehyde compositions |
GB201305687D0 (en) * | 2013-03-28 | 2013-05-15 | Ge Healthcare Ltd | Radiolabelling process |
EP3068747A1 (en) * | 2013-11-13 | 2016-09-21 | GE Healthcare Limited | Dual run cassette for the synthesis of 18f-labelled compounds |
US9988336B2 (en) * | 2014-03-18 | 2018-06-05 | Mayo Foundation For Medical Education And Research | Gaseous F-18 technologies |
NL2014828B1 (en) | 2015-05-20 | 2017-01-31 | Out And Out Chemistry S P R L | Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method. |
JP6827709B2 (ja) * | 2016-04-25 | 2021-02-10 | 日本メジフィジックス株式会社 | 2−[18f]フルオロ−2−デオキシ−d−グルコースの製造方法 |
US10695450B2 (en) | 2016-07-26 | 2020-06-30 | Laboratoires Cyclopharma | Synthesis of a radioactive agent composition |
JP7148121B2 (ja) * | 2018-08-31 | 2022-10-05 | 国立大学法人北海道大学 | 放射性核種18fの精製方法 |
GB202005282D0 (en) * | 2020-04-09 | 2020-05-27 | Blue Earth Diagnostics Ltd | Pharmaceutical Formulations |
JP7127164B2 (ja) * | 2021-01-19 | 2022-08-29 | 日本メジフィジックス株式会社 | 2-[18f]フルオロ-2-デオキシ-d-グルコースの製造方法 |
CN113372399A (zh) * | 2021-06-04 | 2021-09-10 | 江苏华益科技有限公司 | 一种氟[18f]脱氧葡糖注射液的合成方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5425063A (en) * | 1993-04-05 | 1995-06-13 | Associated Universities, Inc. | Method for selective recovery of PET-usable quantities of [18 F] fluoride and [13 N] nitrate/nitrite from a single irradiation of low-enriched [18 O] water |
ZA978758B (en) * | 1996-10-02 | 1999-03-30 | Du Pont Merck Pharma | Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents |
RU2165266C1 (ru) | 2000-06-28 | 2001-04-20 | Центральный научно-исследовательский рентгенорадиологический институт | Способ получения [2-18f]-2-дезоксиглюкозы |
EP1356827A1 (en) | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
ES2347535T3 (es) | 2002-11-05 | 2010-11-02 | Ion Beam Applications S.A. | Estabilizacion de composiciones acuosas de 2-fluoro-2-desoxi-d-glucosa marcada con el isotopo 18f con etanol. |
GB0422004D0 (en) * | 2004-10-05 | 2004-11-03 | Amersham Plc | Method of deprotection |
GB0425501D0 (en) | 2004-11-19 | 2004-12-22 | Amersham Plc | Fluoridation process |
US7235216B2 (en) * | 2005-05-01 | 2007-06-26 | Iba Molecular North America, Inc. | Apparatus and method for producing radiopharmaceuticals |
GB0524851D0 (en) * | 2005-12-06 | 2006-01-11 | Ge Healthcare Ltd | Radiolabelling method using polymers |
MX2008016344A (es) | 2006-06-21 | 2009-02-12 | Ge Healthcare Ltd | Productos radiofarmaceuticos. |
WO2008056481A1 (fr) | 2006-11-09 | 2008-05-15 | Nihon Medi-Physics Co., Ltd. | Agent d'imagerie de diagnostic radioactif |
PL2106808T3 (pl) | 2006-12-21 | 2018-07-31 | Nihon Medi-Physics Co., Ltd. | Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy |
CN101636183B (zh) * | 2007-02-13 | 2014-03-19 | 日本医事物理股份有限公司 | 放射性诊断显像剂的制备方法 |
EP2017359A3 (en) * | 2007-06-11 | 2009-08-05 | Trasis S.A. | Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step |
KR101009712B1 (ko) | 2007-02-22 | 2011-01-19 | 재단법인 아산사회복지재단 | 양성자성 용매와 이에 녹는 염들을 이용한 음이온 교환고분자 지지체로부터의 플루오린-18 플루오라이드 용리와이를 이용한 플루오린-18의 표지방법 |
WO2008106442A1 (en) | 2007-02-27 | 2008-09-04 | Ge Healthcare Limited | Synthesis of [18f] fluoromethyl benzene using benzyl pentafluorobenzenesulfonate |
EP1990310A1 (en) | 2007-04-23 | 2008-11-12 | Trasis S.A. | Method for the preparation of reactive 18F fluoride, and for the labeling of radiotracers, using a modified non-ionic solid support and without any evaporation step |
WO2009045535A2 (en) * | 2007-10-04 | 2009-04-09 | Sloan-Kettering Institute For Cancer Research | Fluorine-18 derivative of dasatinib and uses thereof |
RU2476423C2 (ru) * | 2007-12-19 | 2013-02-27 | Нихон Меди-Физикс Ко., Лтд. | Способ получения радиоактивного, меченного фтором органического соединения |
US20090171272A1 (en) | 2007-12-29 | 2009-07-02 | Tegg Troy T | Deflectable sheath and catheter assembly |
AU2008342628B2 (en) * | 2008-01-03 | 2014-05-01 | Ge Healthcare Limited | Fluoride processing method |
EP2110367A1 (en) * | 2008-04-14 | 2009-10-21 | Bayer Schering Pharma Aktiengesellschaft | Purification strategy for direct nucleophilic procedures |
GB0819293D0 (en) | 2008-10-21 | 2008-11-26 | Hammersmith Imanet Ltd | Radiofluorination |
US20110250137A1 (en) * | 2008-12-04 | 2011-10-13 | Bayer Schering Pharma Aktiengesellchaft | Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
TW201033713A (en) | 2009-03-03 | 2010-09-16 | Wintek Corp | Reflective color-changing liquid crystal display |
EA022897B1 (ru) * | 2010-06-04 | 2016-03-31 | Пирамаль Имэджинг Са | СПОСОБ ПОЛУЧЕНИЯ F-18 МЕЧЕНЫХ Аβ ЛИГАНДОВ |
CN108218650A (zh) * | 2010-12-29 | 2018-06-29 | 通用电气健康护理有限公司 | 洗脱溶液 |
GB201214220D0 (en) * | 2012-08-09 | 2012-09-19 | Ge Healthcare Ltd | Radiosynthesis |
-
2011
- 2011-12-21 CN CN201810077584.0A patent/CN108218650A/zh active Pending
- 2011-12-21 EP EP11808853.3A patent/EP2658831B1/en active Active
- 2011-12-21 KR KR1020197001271A patent/KR102218263B1/ko active IP Right Grant
- 2011-12-21 US US13/997,808 patent/US11504430B2/en active Active
- 2011-12-21 PL PL11808853T patent/PL2658831T3/pl unknown
- 2011-12-21 WO PCT/EP2011/073670 patent/WO2012089594A1/en active Application Filing
- 2011-12-21 BR BR112013015396-2A patent/BR112013015396B1/pt active IP Right Grant
- 2011-12-21 AU AU2011351550A patent/AU2011351550B2/en active Active
- 2011-12-21 KR KR1020137017012A patent/KR20130132892A/ko active Application Filing
- 2011-12-21 JP JP2013546670A patent/JP6018581B2/ja active Active
- 2011-12-21 DK DK11808853.3T patent/DK2658831T3/en active
- 2011-12-21 MX MX2013007699A patent/MX363538B/es unknown
- 2011-12-21 CA CA2823063A patent/CA2823063C/en active Active
- 2011-12-21 ES ES11808853.3T patent/ES2621950T3/es active Active
- 2011-12-21 RU RU2013126979A patent/RU2608932C2/ru active
- 2011-12-21 CN CN2011800634887A patent/CN103270004A/zh active Pending
-
2012
- 2012-12-21 BR BR112014015042-7A patent/BR112014015042B1/pt active IP Right Grant
- 2012-12-21 PT PT201960309T patent/PT3766522T/pt unknown
- 2012-12-21 DK DK20196030.9T patent/DK3766522T3/da active
- 2012-12-21 ES ES20196030T patent/ES2917875T3/es active Active
- 2012-12-21 EP EP20196030.9A patent/EP3766522B1/en active Active
- 2012-12-21 KR KR1020197030135A patent/KR102137348B1/ko active IP Right Grant
- 2012-12-21 PL PL20196030T patent/PL3766522T3/pl unknown
- 2012-12-21 SG SG10201805198TA patent/SG10201805198TA/en unknown
- 2012-12-21 DK DK12806500.0T patent/DK2793954T3/da active
- 2012-12-21 PT PT128065000T patent/PT2793954T/pt unknown
-
2019
- 2019-02-28 US US16/288,650 patent/US20190192660A1/en not_active Abandoned
-
2022
- 2022-10-10 US US17/962,686 patent/US20230068052A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013007699A (es) | Solucion de eluyente. | |
HK1255702A1 (zh) | 用於合成顯像劑的自動反應系統,暗盒和裝置 | |
MX2018008168A (es) | Inhibidores de antigenos de membrana especificos de la prostata (psma) basados en la urea para imaginologia y terapia. | |
MX2022014611A (es) | Compuestos para tomografia por emision de positrones. | |
MX353254B (es) | Radioligandos marcados con fluor-18 y carbono-11 para la formacion de imagenes por tomografia de emision de positrones para proteina cinasa 2 de repeticion rica en leucina (lrrk2). | |
MX2011010295A (es) | Reactivos de radiomarcado y metodos. | |
MX2013012793A (es) | Aminoacidos radiomarcados para imagen de diagnostico. | |
EA201100301A1 (ru) | Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения | |
NZ705827A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
UA110128C2 (uk) | Індолкарбоксаміди та бензімідазолкарбоксаміди як інсектициди та акарициди | |
EP2463263A4 (en) | ISOTOPE-MARKED 2-ARYLPROPIONIC ACID COMPOUNDS, PROCESS FOR PRODUCING THE SAME, MOLECULAR PROBE FOR POSITRON EMISSION TOMOGRAPHY (PET), AND CYCLO-OXYGENASE IMAGING METHOD AND ANALOGY THEREFOR | |
AU2010332841A8 (en) | Prostate specific membrane antigen inhibitors | |
MX2013006202A (es) | Metodo de radioconjugacion. | |
EA201401273A1 (ru) | Набор и способ получения радиофармацевтического препарата | |
LT2625163T (lt) | (3s,3s`) 4,4`-disulfandiil-bis-(3-aminobutan-1-sulfonrūgšties) gavimo būdas | |
MX2015016957A (es) | Sintesis de dicarbamatos a partir de productos de la reduccion de 2-hidroximetil-5-furfural (hmf) y sus derivados. | |
WO2015143019A3 (en) | Gaseous f-18 technologies | |
MX340487B (es) | Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. | |
WO2012157900A3 (ko) | 18f-표지 pet 방사성의약품의 전구체 및 그 제조방법 | |
MX340407B (es) | Simplificacion de proceso para compuesto precursor. | |
WO2012033374A3 (ko) | 1,2,3-트리아졸륨 염을 갖는 설포네이트 전구체, 그 제조방법 및 이를 사용하는 분자내 친핵성 플루오르화반응 | |
NZ708849A (en) | Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma | |
MX2011011191A (es) | Nuevas moléculas precursoras para marcadores de pet marcados con f-18. | |
WO2009033584A3 (en) | Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols | |
MX2013007186A (es) | Purificacion de compuesto precursor mediante cristalizacion. |